Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lowdell

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Cytotherapy|October 10, 2017
The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015Hilary Ireland, Max H P Gay, Helen Baldomero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptorsMay Sabry, Maria Tsirogianni, Ismail A Bakhsh, et al.
Plos One|June 11, 2015
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I TrialPanagiotis D Kottaridis, Janet North, Maria Tsirogianni, et al.
Cytotherapy|January 4, 2023
Human platelet lysate enhances proliferation but not chondrogenic differentiation of pediatric mesenchymal progenitorsOliver F W Gardner, Natacha Agabalyan, Ben Weil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantationKarl S Peggs, Kirsty Thomson, Edward Samuel, et al.
Journal of Translational Medicine|November 20, 2014
CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimersLorea Beloki, Miriam Ciaurriz, Cristina Mansilla, et al.
Journal of Translational Medicine|May 21, 2015
Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral bloodLorea Beloki, Miriam Ciaurriz, Cristina Mansilla, et al.
Plos One|August 17, 2013
CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cellsAndrea Knight, Hilal Arnouk, William Britt, et al.
Plos One|June 27, 2019
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signaturesMay Sabry, Agnieszka Zubiak, Simon P Hood, et al.
JACC. Case Reports|May 27, 2021
Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch OperationFilippo Rapetto, Demetris Taliotis, Qiang Chen, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Cytotherapy|October 10, 2017
The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015Hilary Ireland, Max H P Gay, Helen Baldomero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptorsMay Sabry, Maria Tsirogianni, Ismail A Bakhsh, et al.
Plos One|June 11, 2015
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I TrialPanagiotis D Kottaridis, Janet North, Maria Tsirogianni, et al.
Cytotherapy|January 4, 2023
Human platelet lysate enhances proliferation but not chondrogenic differentiation of pediatric mesenchymal progenitorsOliver F W Gardner, Natacha Agabalyan, Ben Weil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantationKarl S Peggs, Kirsty Thomson, Edward Samuel, et al.
Journal of Translational Medicine|November 20, 2014
CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimersLorea Beloki, Miriam Ciaurriz, Cristina Mansilla, et al.
Journal of Translational Medicine|May 21, 2015
Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral bloodLorea Beloki, Miriam Ciaurriz, Cristina Mansilla, et al.
Plos One|August 17, 2013
CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cellsAndrea Knight, Hilal Arnouk, William Britt, et al.
Plos One|June 27, 2019
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signaturesMay Sabry, Agnieszka Zubiak, Simon P Hood, et al.
JACC. Case Reports|May 27, 2021
Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch OperationFilippo Rapetto, Demetris Taliotis, Qiang Chen, et al.
Pageof 8